Janux Therapeutics Inc., a clinical-stage biopharmaceutical company, will host a virtual R&D Day on July 24, 2025, at 1:30 PM PT. During the event, the company will present product candidates from its preclinical pipeline that are set to move into clinical trials. These programs leverage Janux's proprietary technology platforms, TRACTr and TRACIr, to address unmet medical needs.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.